Impact of the first surge of the COVID‐19 pandemic on a tertiary referral centre for kidney cancer

Abstract

The first surge of the COVID-19 pandemic severely impacted diagnosis, referral and treatment of kidney cancer at a tertiary referral centre. With a policy of prioritization and COVID-protected pathways, capacity for time-sensitive oncological interventions was maintained and no immediate clinical harm was observed.